PARI Respiratory Equipment Featured on Oxyg...(er of the world's leading breath-enhance...),Health
Navigation Links
PARI Respiratory Equipment Featured on Oxygen Network
Date:9/5/2008
er of the world's leading breath-enhanced reusable nebulizer, the PARI LC PLUS, and the new PARI LC Sprint nebulizer line, PARI also manufactures the award winning PARI TREK S compact compressor, Bubbles the Fish II aerosol mask, and durable PARI PRONEB Ultra II. PARI's Vortex anti-static valved holding chamber improves the aerosol deposition of metered dose inhalers (MDI's). PARI's North American headquarters is in Midlothian, VA with worldwide headquarters in Starnberg, Germany. Online at http://www.Pari.com
Additional information is available by contacting Ayars & Associates at 805-845-5682 or at 804-253-7274 x711.
'/>"/>
| SOURCE PARI Respiratory Equipment, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Novel virus detection identifies new viruses in study of respiratory infections and asthma attacks
2. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
3. Instrumentation Laboratory Named Top of Class by Respiratory Care Managers
4. Perrigo Confirms Filing for Generic Version of Mucinex(R) and Announcement of Lawsuit by Adams Respiratory
5. Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R)
6. Fire Season: Respiratory Health a Concern
7. Alpha-1 Foundation President to Give Keynote Address at 53rd Annual Respiratory Congress of the AARC Foundation and Activities
8. Amira Pharmaceuticals Announces Favorable Phase 1 Clinical Trial Results for Lead Product Candidate AM103 and Initiates Clinical Studies for the 2nd Entry Molecule for the Treatment of Respiratory and Cardiovascular Disease
9. Recently discovered virus associated with pediatric respiratory tract infection in Germany
10. New Study Demonstrates Ramelteon Does Not Exacerbate Respiratory Depressant Effects in Patients With Moderate-to-Severe COPD
11. Kids Respiratory Virus Season Off and Running
Post Your Comments:
(Date:1/8/2009)...8 Today, the National H... several national leadership organizations issued ...hospice care and protection of the Medicare Hospic...sharing this unified message about end-of-life car...iative Medicine, Hospice and Palliative Nurses Ass...
(Date:1/8/2009)...mber Tom Torlakson Introduces AB 89 , , SACRAME...oday, Lung Cancer Alliance-California (LCA-CA), ha...1th District) for his continued leadership in intr...cer research. For the third consecutive year, leg...eing considered in the California Legislature. ,...
(Date:1/8/2009)... cholesterol more effectively than Zocor , ...arly a year of review, U.S. health officials said ...the controversial cholesterol-lowering drug Vytori... there was no significant difference in carotid ar... patients taking the drug Zocor. , But, the age...
(Date:1/8/2009)...ition in 2009 Continues Growth Trend , , NORTH ...- IPC The Hospitalist Company, Inc. (Nasdaq: IPC...p practice company, announced today that it has ac...are Consultants, Inc. (MACC) in St. Louis, Missour...in the St. Louis market, where IPC has established...
Breaking Medicine News(10 mins):Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 2Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 3Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 4Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 5Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 6Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 7Health News:Lung Cancer Alliance Applauds New Legislation Funding Lung Cancer Research 2Health News:FDA Backs Cholesterol Drug Vytorin 2Health News:IPC The Hospitalist Company Acquires Missouri Practice Group 2[0] National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future[0] Lung Cancer Alliance Applauds New Legislation Funding Lung Cancer Research[0] FDA Backs Cholesterol Drug Vytorin[0] IPC The Hospitalist Company Acquires Missouri Practice Group
...e literally found the needle in the haystack as ye...logy coupled// to help to discover hitherto unknow...ery expected to do much in the prevention and trea...ith considerable excitement and speculation. Scie...
...failure (CHF) patients in rural and remote areas o...and support services//, according to health resear...ecently hospitalised patients to help optimise the...ey leave the hospital. But according to Ms Robyn...
...ise have been prescribed for the officials of Thai...gkol Na Songkhla directed// his staff to be health...a conference promoting health, he said that obesit...ming rate which leads to diabetes and heart diseas...
...ve discovered that the same genetic regulator that...pment also plays a central role in the development... experiments on mice with such gliomas, they showe...particular regulatory protein, Olig2, almost compl...
Other Medicine News:Health News:New Gene Linked to Autism Discovered 2Health News:'Gateway' Gene Discovered for Brain Cancer 2(Date:1/7/2009)..., MEMPHIS, Tenn., Jan. 7 /PRNewswire-USNewswire...e that predict a high likelihood of relapse in chi...hough the researchers caution that further researc...called IKZF1 or IKAROS, lead to leukemia relap...or future diagnostic tests to assess the risk of t...
(Date:1/7/2009)..., BEIJING, Jan. 7 Tiantan Puhua...puhua.com ), the worldwide leader in using stem ce...nnounced today six new globally experienced additi...cantly expand the hospital,s treatment capabilitie...tients. The six senior doctors include the disting...
(Date:1/6/2009)..., COMMACK, N.Y., Jan. 6 In rece...omer, University of Memphis , scientists found th...Carn(R), is the first and only proven ingredient t...; thereby increasing blood nitrate/nitrate (NOx) i...sodilator and enables an increase in blood flow to...
(Date:1/6/2009)..., PARSIPPANY, N.J., Jan. 6 ...alty pharmaceutical company, announced today that ...e III SIMPLE trials to evaluate the,safety and ef...f EXPAREL(TM),(DepoBupivacaine) for prolonged pos...udies in hemorrhoidectomy and in total knee,arthr...
Breaking Medicine Technology:Gene Abnormality Found to Predict Childhood Leukemia Relapse 2Gene Abnormality Found to Predict Childhood Leukemia Relapse 3Gene Abnormality Found to Predict Childhood Leukemia Relapse 4Gene Abnormality Found to Predict Childhood Leukemia Relapse 5Gene Abnormality Found to Predict Childhood Leukemia Relapse 6Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 2Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 3US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream 2Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 2Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 3NASA enhanced dust storm predictions to aid health community 5629 1NASA enhanced dust storm predictions to aid health community 5629 2NASA enhanced dust storm predictions to aid health community 5629 3Carmex Takes Moisture to the Next Level With New Carmex Moisture Plus 28TM 29 28007 1Notice of conference call and webcast 8677 1Notice of conference call and webcast 8677 2Cialis May Help Ease Pulmonary Hypertension 28000 1Cialis May Help Ease Pulmonary Hypertension 28000 2[1] Gene Abnormality Found to Predict Childhood Leukemia Relapse[0] Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients[0] US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream[3] Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment
...akthrough Will Aid in Developing Therapies to Prev...RYVILLE, Calif., May 10, 2007 /PRNewswire/ -- Kine...lopment company, announced,today the first method ...es in animals through the pathway known as reverse...n mechanism by which excess,cholesterol can be rem...
...POLIS, France, May 11, 2007 /PRNewswire-FirstCall/...pdate on the phase 2a,study for NCX 1000, which is... Pharma Inc. A preliminary analysis of 11 patient...tension confirmed,the safety profile of NCX 1000 b...pport the continuation of this clinical trial. As ...
Other Medicine Technology:KineMed Presents Data Measuring Changes in Reverse Cholesterol,Transport for the First Time 2KineMed Presents Data Measuring Changes in Reverse Cholesterol,Transport for the First Time 3NicOx Provides an Update on the Phase 2a Study for NCX 1000,Conducted With Axcan 2NicOx Provides an Update on the Phase 2a Study for NCX 1000,Conducted With Axcan 3...able laparoscopic 12 mm linear cutting stapler for...ium staples., ,The stapler places two triple, sta... the knife divides the tissue in between. The inst...e surgical procedure: it can be reloaded up to 7 t...
...g unit for reloadable rotating (360°) linear s...tion and anastomosis with titanium staples., ,The...nium staples and simultaneously the knife divides ...for multiple use during a single surgical procedur...
ENDO GIA ROTICULATOR™ Single Use Loading Units with Titanium Staples for use with the ENDO GIA™ Universal and GIA™ Universal Instrument (030403) Single Use Instrument (030449).
... Thoracic Endoscopic Linear Cutter has application...urgical procedures for transection, resection, and...taple line buttressing materials such as bovine pe... for a total of eight firings. Different cartridge...
Medicine Products:| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |